North America Soft Tissue Repair Market

North America Soft Tissue Repair Market Size (2023 to 2028)

The size of the North America Soft Tissue Repair Market is anticipated to grow at a 7.12% CAGR from 2023 to 2028. This value is estimated that the North American market was valued at USD 5.96 billion in 2023 and is relied upon to achieve USD 8.41 billion by 2028.

Y-O-Y growth in the obese population and increasing number of sports-related injuries in North American countries are majorly driving the market growth. According to the American Orthopedic Society for Sports Medicine, 0.1 million to 0.2 million cases anterior cruciate ligament injuries occur every year in the United States. The increasing number of product launches, the rising number of accidents leading to hospital admissions, and the increasing number of hospitals in the North American countries are estimated to accelerate the growth rate of the market.

Growing incidence of hernia repair, Y-O-Y growth in breast cancer incidence, an increasing number of treatment options for aging people are also expected to contribute a boost to the development of the North America Soft Tissue Repair Market.

Unpromising reimbursement policies and the expensive nature associated with the soft tissue repair procedure are expected to limit the market growth to a small extent. The existence of alternative treatments during the time of operation is challenging the market. Lack of knowledge in people and the shortage of human tissue availability throughout North America some of the considerable challenges that may obstruct the market growth to a limited extent.

This research report on the North America Soft Tissue Repair Market has been segmented and sub-segmented into the following categories:

• By Product: Mesh/Tissue patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments
• By Application: Hernia, Dural, Orthopedic, Skin, Dental, Vaginal, Breast Augmentation
• By Country: The United States, Canada, and Rest of North America

Regional Analysis:

North America is anticipated to rule the global market with the highest share during the forecast period. It is due to the increasing demand for minimally invasive surgeries and technological advancements.

An increase in the demand for treatment and a rise in patients' awareness about different treatment options will dominate the market in North America. An increase in the disposable income and changing lifestyles among populations in developing economies, increasing hernia repairs, growing incidence of breast cancer, and an increase in the treatment option for aging, especially for the geriatric population and minimally invasive procedures, drive the market growth of soft tissue repair.

The United States market is considered the dominating country in North America due to the appearance of many key players and the existence of the baby boomer population integrated along with the increasing trauma cases.

Following the United States in leading the market due to advanced technologies in orthopedic repair products producing more profitable opportunities in the market, Canada is expected to surge the market growth.

Companies playing a dominant role in the North America Soft Tissue Repair Market profiled in this report are LifeCell Corporation, Organogenesis, C.R. Bard Inc., Johnson & Johnson, Covidien plc, Arthrex Inc., Smith & Nephew plc, Integra Lifesciences Corporation, Wright Medical Technology, and Stryker Corporation.